NDC 66993-233 – Dasatinib
Dasatinib 20 mg/1 · Tablet · Oral
Product NDC66993-233
Product details
- Brand name
- Dasatinib
- Generic name
- Dasatinib
- Labeler
- Prasco Laboratories
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA021986
- Marketed since
- September 3, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 20 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 66993-233-60 | 1 BOTTLE in 1 CARTON (66993-233-60) / 60 TABLET in 1 BOTTLE | Sep 3, 2024 |
Other Dasatinib products
- 59651-542 Dasatinib 20 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-543 Dasatinib 50 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-544 Dasatinib 70 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-545 Dasatinib 80 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-546 Dasatinib 100 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-547 Dasatinib 140 mg/1 · Tablet · Aurobindo Pharma Limited
- 70748-212 Dasatinib 100 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-213 Dasatinib 140 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-208 Dasatinib 20 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-209 Dasatinib 50 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-210 Dasatinib 70 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-211 Dasatinib 80 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.